Arbutus Biopharma Corp. (ABUS)
NGS · Common · CUSIP 03879J100
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for ABUS and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
03879J100 (prev. 87911B209 )
Market Cap
Small Cap
Previous Symbol
TKMR (changed 8/3/2015)
Previous Name
Tekmira Pharmaceuticals Corp.
Business: Arbutus Biopharma Corp.biopharmaceutical company dedicated to discovering, developing and commercializing a cure for patients suffering from chronic Hepatitis B infection. Arbutus is developing multiple drug candidates, each of which have the potential to improve upon the standard of care and contribute to a curative combination regimen.
Notes: August 3, 2015, Tekmira Pharmaceuticals Corp. changed its name to Arbutus Biopharma Corp., ticker symbol ABUS). The name change affirms the successful integration of OnCore BioPharma and Tekmira Pharmaceuticals into a combined company with the goal of delivering a cure for chronic HBV.

Company Contact

CEO
Michael J. McElhaugh
CFO
David C. Hastings
Headquarters
701 Veterans Circle, Warminster, PA 18974
Phone
267-469-0914
Fax
604-419-3201
Investor Relations
Pam Murphy · 604-419-3200 · ir@arbutusbio.com
SEC EDGAR Filings
View filings »
SEDAR+ Filings
Go to SEDAR+ »